Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response of retinal vessels to ranibizumab in branch retinal vein occlusion
2007-002826-31Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2007
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ranibizumab in cystoid macular edema (CME) and branch retinal vein occlusion (BRVO), sponsored by Medical University of Vienna. Primary endpoint: Retinal vessel diameters. Started Aug 2007; status: completed.
02
Drugs
ranibizumab
03
Conditions
cystoid macular edema (CME)branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on 2007-002826-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002826-31.